6505-14-563-6004
Formoterol Fumarate Capsules For Inhalation
6505145636004 145636004 AMM 5706779 NMA 697269518010
Capsules should be administered only by the oral inhalation route and only using the the appropriate inhaler. Capsules should not be ingested orally (i.e. swallowed). Capsules should always be stored in the blister, and only removed IMMEDIATELY BEFORE USE. View more Formoterol Fumarate Capsules For Inhalation
Managed by France
NSN Created on 24 Feb 2010
Data Last Changed
January 2023
January 2023
NATO Update Count
1
1
NATO Data Quality
Marketplace 6505-14-563-6004
Need Help?
Request a Quotation from participating marketplace vendors
Request a Quotation from participating marketplace vendors
Related Documents 6505-14-563-6004 1+ Documents (More...)
AMM 5706779 NMA 697269518010 Capsules should be administered only by the oral inhalation route and only
6505-14-563-6004 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/fr 6505-14-563-6004
RQST Updated Every Day 6505-14-563-6004 RQST NE Related Documents 6505-14-563-6004 1+ Documents
6505-14-563-6004 1+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/fr 6505-14-563-6004
RQST Updated Every Day 6505-14-563-6004 RQST NE Related Documents 6505-14-563-6004 1+ Documents
Restrictions 6505-14-563-6004
End Users 6505-14-563-6004
- France (ZF)
Approved Sources 6505-14-563-6004
- Part Number
- Manufacturer
- Status
- AMM 5706779
- Manufacturer
- FAVU1 - Novartis Pharma Sas (Active)
- Primary Buy
- Primary Buy
- NMA 697269518010
- F3020 - Dapsa (Direction Des (Active)
- NATO Reference
- NATO Reference
Similar Supply Items to 6505-14-563-6004
